ARCHIVES

FDA, ASCO Meet to Review Drug Approval Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 17 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

Recommendation By Patients; report Of Protocol Committee

August 9, 1996

Roche Reports New Avastin Results As FDA Mulls Breast Cancer Indication.

February 15, 2008

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

July 26, 2013

NCI awards $42 million for prevention trials consortium.

December 5, 2003

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

DCT Advisors OK Recompetition Of Drug Contacts

March 15, 1991